Incidental skin malignancies in teledermatology and in-person cohorts in the Veterans Affairs Health System
To the Editor: Teledermatology (TD) utilizes electronic imaging and data sharing to make dermatologic care more accessible. Store-andforward TD reduces face-to-face (FTF) visits and has 78.6%-93.9% diagnostic concordance in identifying skin neoplasms.
1,2 TD relies on skin examinations performed by primary care providers (PCP), and studies show that when compared with dermatologists, PCP skin examinations are associated with decreased detection of skin malignancies.
3 Accordingly, TD is limited by the risk of missed skin malignancies. 4 Methods to limit the number of incidental malignancies in TD have not been established. To evaluate these implications, we compared the rate of incidental skin malignancy found by dermatologists in patients referred by PCP versus those referred by TD.
We retrospectively reviewed a nonrandomized, demographically matched patient cohort who consulted for TD or a FTF visit with a PCP from December 2011 to January 2015 located in the community-based outpatient clinics in Charlottesville, Virgina. We compared 350 TD visits with 121 FTF visits. TD was employed using the storeand-forward approach. Trained TD imagers were directed to take macro images of lesions specified by a PCP. TD and FTF referrals were conducted by a PCP. We documented incidental skin malignancies found by staff dermatologists in both groups for lesions that were not included by either the TD images or referring PCP in the consult. All lesions were confirmed by biopsy. TD consults that did not require FTF visits were completed without visiting a PCP and were recorded as a visit saved. Although systematic differences might exist in these groups, all patients in this study received recommendations from a boardcertified dermatologist. From our TD patient cohort (n ¼ 350), 185 (53%) had nonmalignant lesions that did not require dermatology follow-up, and 82 (23%) required biopsies because of concern for malignancy. Of the 165 TD patients who were evaluated by a dermatologist, 6 (3.6%) had incidental skin malignancy. In the 121 FTF cohort, 31 (25%) required biopsy, and 3/121 (2.5%) had incidental skin malignancy. Table 1 .
J AM ACAD DERMATOL NOVEMBER 2017 965 FTF visits were decreased by 53% (185/305) in the TD group, consistent with a previous TD study. 5 Incidental malignancy found in the TD cohort was similar to (or slightly higher than) the rate found in the FTF cohort (3.6 % vs 2.5%, respectively), consistent with a previous study. 4 Eight out of the 9 patients with incidental malignancy were referred for a different neoplasm found during the initial PCP evaluation, suggesting we cannot infer a 3.6% malignancy rate for the nonreferred TD patients because these neoplasms might have been lower risk conditions (Fig 1, Table I ). TD patients who were not seen in-person by a dermatologist had TD diagnoses that were nonmalignant in nature and might be at lower risk for incidental malignancy. However, the true missed malignancy rate might be greater than 3.6%, which would have implications for TD. These findings suggest that further investigations should focus on strategies that maximize the benefits of TD to those with limited access to dermatologic care, while limiting the potential for missed malignancies. Because 8/9 incidental malignancies were noted in patients with pre-existing neoplasia, strategies should include expanded protocols for TD imagers and PCPs focusing their FTF visits on patients with pre-existing neoplasia.
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